ArticleOncology letters2017

Elevation of serum CEA and CA15-3 levels during antitumor therapy predicts poor therapeutic response in advanced breast cancer patients.

Yue Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.